METHODS FOR THE USE OF A PD-1 X CTLA-4 BISPECIFIC MOLECULE

The present invention is directed in part to dosing regimens for administering a PD-1 x CTLA- 4 bispecific molecule for the treatment of cancer, and other conditions. The invention is directed in part to the use of such molecules, and to the use of pharmaceutical compositions and pharmaceutical kits...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Alexey Yevgenyevich BEREZHNOY, Bradley James SUMROW, Jon Marc WIGGINTON, Ezio BONVINI, Sharad SHARMA
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!